KISQALI TV Spot, 'More Time' - iSpot.tv
WEBFeb 23, 2021 · Real-Time Video Ad Creative Assessment. KISQALI is a prescribed oral medication which is intended to treat people who have been diagnosed with HR+ and HER2- breast cancer when taken regularly as prescribed. Published. February 23, …
FDA chides Novartis for ‘false or misleading’ Kisqali TV spot ...
WEBJan 23, 2024 · After reviewing an ad for breast cancer drug Kisqali, the agency accused Novartis of making false or misleading representations about the treatment’s efficacy.
KISQALI TV Spot, 'Have Both' - iSpot.tv
WEBSep 11, 2023 · Check out KISQALI's 60 second TV commercial, 'Have Both' from the Rx: Cancer industry. Keep an eye on this page to learn about the songs, characters, and celebrities appearing in this TV commercial. Share it with friends, then discover more great TV commercials on iSpot.tv.
KISQALI TV Commercials
WEBWatch, interact and learn more about the songs, characters, and celebrities that appear in your favorite KISQALI TV Commercials. Watch the commercial, share it with friends, then discover more great KISQALI TV commercials on iSpot.tv.
FDA scolds Novartis over a misleading TV ad for a breast cancer
WEBJan 19, 2024 · T he U.S. Food and Drug Administration scolded Novartis for making false and misleading statements about a best-selling breast cancer treatment in a television ad in 2022. In a Nov. 18 letter,...
WEBThe Office of Prescription Drug Promotion (OPDP) of the U.S. Food and Drug Administration (FDA) has reviewed the promotional communication, a direct-to-consumer broadcast advertisement (TV ad),...
National Advertising Division Finds Novartis Breast Cancer Drug …
WEBEli Lilly, manufacturer of the competing Verzenio drug to treat metastatic breast cancer, challenged survival benefit claims made in Novartis’ advertising campaign for Kisqali. Metastatic breast cancer is presently incurable, however, current treatments can reduce the spread of cancer to other parts of the body, consequently extending time ...
Novartis pulls contentious claims in DTC ad campaign for Kisqali
WEBJan 23, 2023 · Novartis has pulled questionable efficacy claims in a direct-to-consumer ad campaign for its breast cancer drug Kisqali after the National Advertising Division (NAD) ruled they didn’t stack...
Novartis Overstates Kisqali Effectiveness in TV Ad, FDA Says in ...
WEBJan 24, 2024 · The FDA has warned Novartis that its direct to consumer TV ad for its breast cancer drug Kisqali (ribociclib) makes false or misleading representations about the drug’s efficacy, sending the company an untitled letter.
Novartis touts survival edge in Kisqali's TV debut
WEBMar 4, 2020 · Novartis has launched its first TV spot for the breast cancer drug, a member of the CDK 4/6 class, in a stepped-up effort to raise awareness. The new commercial comes on the heels of two...
- Some results have been removed
Skip to content